bpc-157 clinical evidence human studies Here's a nice graphic on that you can hand out to patients who inquire about it. Thanks to Chris Centeno, M.D The Stable Gastric Pentadecapeptide BPC
Description
10.1016/j.sbi.2011.01.007
Flaherty, S
Janus Kinase (JAK) Inhibitors: Leading the Revolution JAK inhibitors have emerged as one of the most promising new treatments for vitiligo
Best peptide approach : GHK-Cu primary, BPC-157 supportive Protocol : GHK-Cu: 2mg daily (ongoing) BPC-157: 250-500mcg twice daily (as needed) Important : Continue medical treatment
The acupuncture group were subject to 28-day cycles of an acupuncture regimen in addition
